Radial endobronchial ultrasound in diagnosing peripheral lung lesions in a high tuberculosis setting by unknown
RESEARCH ARTICLE Open Access
Radial endobronchial ultrasound in
diagnosing peripheral lung lesions in a
high tuberculosis setting
Adrian Chan1*, Anantham Devanand1,2, Su Ying Low1,2 and Mariko Siyue Koh1,2
Abstract
Background: Current data for the utility of radial endobronchial ultrasound (EBUS) in investigating peripheral lung
lesions (PLLs) has been restricted to populations with low pulmonary tuberculosis (TB) incidence. The aim of this
study was to assess the diagnostic utility of radial EBUS with guide sheath in the diagnosis of peripheral lung
lesions in Singapore, a high TB incidence setting.
Methods: A post-hoc database analysis was performed. 123 consecutive patients with computed tomographic
evidence of PLLs who underwent radial EBUS guided bronchoscopy were included.
Results: The final diagnosis was malignancy in 76 cases and benign in 44 cases. Radial EBUS guided bronchoscopy
had a sensitivity of 65.8 % for malignancy, positive predictive value of 100 %, negative predictive value of 62.9 %,
and a diagnostic accuracy of 82.5 %. 22 patients had a final diagnosis of pulmonary TB. The diagnostic sensitivity for
pulmonary TB was 77.3 %, with a positive predictive value of 100 %, negative predictive value of 95.2 % and a
diagnostic accuracy of 95.8 %. Overall, 58.8 % of pulmonary TB cases relied on histology to make an early diagnosis.
Conclusion: Radial EBUS guided bronchosopy is useful in investigating PLLs in a high TB incidence setting. Our
data also suggests that radial EBUS is a more rapid diagnosis technique for tuberculous lesions.
Background
Peripheral lung lesions (PLL) are defined as lesions that
are not visualized within the bronchial tree during flex-
ible bronchoscopy [1, 2]. Differential diagnoses can in-
clude both malignant causes and benign causes such as
infection and inflammation. The diagnostic yield of flex-
ible bronchoscopy in the biopsy of such lung lesions has
been reported to be 54 % for malignant lesions and 41 %
for benign lesions [3, 4]. To circumvent limitations of flex-
ible bronchoscopy for such lesions, adjunct diagnostic
tools have been proposed to guide bronchoscopic biopsies.
Various studies have confirmed that radial EBUS is a mo-
dality that can improve diagnostic sensitivity [5–10]. The
American College Of Chest Physicians Lung Cancer
Guidelines has recommended using radial endobronchial
ultrasound (EBUS) as an adjunct imaging modality for pa-
tients with peripheral lung nodules, where expertise and
equipment are available. It can be used especially in cases
where tissue diagnosis is required due to the uncertainty
of diagnosis or poor surgical candidacy (Grade 1C evi-
dence) [11]. Such guidelines are targeted at populations of
an intermediate probability of lung cancer depending on
clinical history, radiological stability and CT signs of ma-
lignancy such as size, spiculated borders, and absence of
calcification.
However, pulmonary tuberculosis (TB) can also present
as a peripheral lung lesion with varying disease activity:
active infection, tuberculous granulomas, or inflammatory
scars. In populations where tuberculosis is endemic,
benign-looking lesions (based on clinical history and
radiological characteristics) cannot always be managed
with radiological surveillance because of both therapeutic
implications and public health reasons. Delayed diagnosis
and empiric tuberculosis treatment in an era of drug re-
sistance will undermine the global control of TB [12, 13].
Percutaneous lung biopsy and surgical resection are op-
tions that offer a high diagnostic yield, but these will
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expose patients with a potentially curable infection to un-
necessary procedural risks.
The diagnostic yield of conventional (transbronchial
biopsy) TBB for pulmonary TB has been reported to be
55–75.8 % [14, 15]. The current literature on radial
EBUS is limited mostly to populations with high lung
cancer prevalence and there is limited data on the role of
radial EBUS guided bronchoscopic biopsy for PLLs in pop-
ulations with a high incidence of pulmonary TB [9–11].
We aimed to evaluate the diagnostic yield of radial EBUS-
guided sampling in PPLs for both malignant and benign le-
sions (including TB).
Methods
Study design and setting
This is a retrospective database review of an established
database in Singapore General Hospital, a 1700-bedded
university-affiliated tertiary hospital. A database of all
adult consecutive patients at our hospital who consented
for and underwent flexible bronchoscopy using radial
EBUS was established in August 2008. This project was
supported by government funding from the Ministry of
Health, Singapore (under Health Services Development
Project). As such, the project was closely audited by the
funding agency and the Singapore General Hospital
Quality Management Department. Therefore, complete-
ness of data collection, diagnostic yield, technical details
and complications were ensured. The study was ap-
proved by SingHealth Centralised Institutional Review
Board (CIRB: 2008/458/B).
Study population
All consecutive patients who had PPLs and had under-
gone radial EBUS were considered for inclusion. Exclu-
sion criteria were: 1) CT findings with any of the
following: PPL < 1 cm diameter, endobronchial lesions,
airway narrowing, pure ‘ground-glass’ appearance, or ab-
sence of CT bronchus sign, and 2) Presence of a sub-
mucosal lesion seen during flexible bronchoscopy. The
study period was between August 2008 and December
2011 and data for included patients were reviewed
retrospectively.
Study procedures
Bronchoscopy was performed under moderate sedation
using a combination of midazolam and fentanyl. The
pre-test probability of pulmonary TB was considered
high if there was fever and sputum production clinically
and if there was cavitation radiologically. All these pa-
tients had negative acid-fast bacilli smears prior to
endoscopy.
During the procedure, the bronchoscope was maneu-
vered to the suspected sub-segmental airway and BAL
was first performed. This was followed by insertion of a
20-MHz radial EBUS probe (UM-S20-20R; Olympus,
Tokyo, Japan) with an external diameter of 2.2 mm via a
guide-sheath through the 2.8 mm working channel of
the flexible bronchoscope (Exera BF-1 T260; Olympus,
Tokyo, Japan) with an outer diameter of 6.0 mm. The le-
sion was localized when the ‘snow-storm’ ultrasound ap-
pearance of aerated-normal lung was replaced with a
soft tissue density on the processor monitor (EU-ME1;
Olympus, Tokyo, Japan). The radial probe was adjusted
until the probe was within the lesion. This was contin-
ued until all visible sub-segments were explored. Ultim-
ately if the radial probe could not be placed within the
lesion, the best CT-bronchoscopic correlation was used.
Then, the probe was withdrawn leaving the guide-sheath
in situ. Aliquots of 20 ml of normal saline solution were
instilled and retrieved immediately with negative suction
pressure that was adjusted to avoid airway collapse. A
total of 100 to 200 ml of normal saline was instilled in
each patient. Forceps biopsies were then taken under
fluoroscopic guidance. Fluoroscopy served the dual pur-
poses of ensuring that the guide-sheath was not dis-
lodged and the forceps were closed at a safe distance
from the pleura. Aliquots from the pooled BAL sample
were sent for Gram stain, acid fast bacilli (AFB) smear,
microbiologic (including tuberculous) culture and cyto-
logic examination; forceps biopsies were sent for histo-
pathology and tuberculous cultures.
Malignant PPLs was diagnosed based on histological
evidence of malignancy obtained from bronchoscopic bi-
opsies. A diagnosis of tuberculosis was derived based on
the following outcomes: a) presence of positive cultures
or b) demonstration of necrotizing granulomatous in-
flammation on histology with or without positive micro-
biology or c) clinical suspicion of TB and response to
empirical anti-tuberculous treatment with radiological
resolution of PPL [16]. All patients with non-diagnostic
bronchoscopy were either subjected to an alternative bi-
opsy (usually CT-guided or surgical biopsy) or followed
up with a combination of radiology and clinical surveil-
lance for a minimum of 12 months, depending on the
managing physician’s discretion. When an alternative
diagnosis was established, these cases were designated as
false negatives. If the patient showed both clinical and
radiological stability, then the lesion was considered
likely to be pulmonary scar tissue and designated as a
true negative.
Statistical analysis
Statistical analysis was performed using a statistical
package for social sciences software (Version 21.0). Con-
fidence intervals of 95 % were reported, and all tests
were 2-sided. Continuous variables were expressed as
mean ± standard deviation, and comparisons were ana-
lysed with t-tests. Outcomes for categorical variables
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were analysed using chi-square test or Fisher’s exact test.
Sensitivity, specificity, predictive values and accuracy
were calculated based on standard definitions. p < 0.05
was regarded as being statistically significant.
Results
Patient characteristics
Overall, 123 patients underwent bronchoscopy with ra-
dial EBUS guidance. 3 patients were excluded from ana-
lysis as the final diagnosis could not be determined due
to death (2 patients) or loss to follow-up (1 patient)
[Table 1]. The mean age of the patients was 62.6 ±
12.6 years and 60 % were males. The median number of
forcep-biopsies performed was 5 (range 1–13). The me-
dian midazolam dose was 3.0 mg (range 0–10 mg) and
the median fentanyl dose was 50.0 mcg (range 0–200
mcg). Patients diagnosed with malignant lesions were
significantly older than those with benign lesions (mean
age: 65.1 ± 10.3 vs. 58.2 ± 15.0 years, p = 0.004).
Diagnostic yield and outcomes
The final diagnosis was malignancy in 76 cases, giving
an incidence of 62.5 %. Radial EBUS for malignant le-
sions had a sensitivity of 65.8 % (95 % CI: 53.9–76.0),
positive predictive value of 100 % (95 % CI: 91.1–100),
negative predictive value of 62.9 % (95 % CI: 50.4–73.9),
and an overall diagnostic accuracy of 82.5 % [Table 2].
There was no difference for yield between malignant
and non-malignant lesions (p = 0.308). 10 lesions were
diagnosed to be pulmonary metastases; the broncho-
scopic diagnostic yield for such lesions was only 20 %.
21 of 26 patients with non-diagnostic EBUS-guided sam-
pling underwent further invasive investigations to con-
firm the diagnosis of malignancy [Table 3].
22 patients in our study group had a final diagnosis of
pulmonary TB. Radial EBUS guided bronchoscopy suc-
cessfully diagnosed pulmonary TB in 17 out of 22 cases,
providing a diagnostic sensitivity of 77.3 % (95 % CI:
54.2–91.3), positive predictive value of 100 % (95 % CI:
77.1–100), negative predictive value of 95.1 % (95 % CI:
88.5–98.2) and a diagnostic accuracy of 95.8 % [Table 4].
Mycobacterial culture was positive in 15 of 17 (88.2 %)
cases. These were obtained from BAL in all cases, whilst
6 cases yielded a positive culture from transbronchial bi-
opsies as well. 10 of 22 patients demonstrated necrotiz-
ing granulomatous inflammation on their TBBs. In this
subgroup with positive histology, all patients had negative
AFB smears on bronchoscopic samples, and 2 patients
had negative tuberculous cultures. In patients with nega-
tive histologic findings on biopsies, the main pathologic
findings were chronic inflammatory changes without
granulomatous inflammation (11 patients) or necrotic ma-
terial (1 patient).
Data for ultrasound probe location was available for
105 patients. The probe was within the lesion in 78 pa-
tients (74.3 %), adjacent to the lesion in 22 patients
(21.0 %), and outside of the lesion in 5 patients (4.7 %).
Yield was significantly higher when the probe was posi-
tioned within the lesion (78.2 %) than when the probe was
adjacent to or outside the lesion (44.4 %) (p = 0.001).
Mean lesion diameter was 25.6 ± 12.4 mm, with 71 pa-
tients (59.7 %) having lesions greater than 20 mm diam-
eter. Mean lesion diameter was similar for malignant
lesions (26 ± 12 mm) when compared to benign lesions
(24 ± 13 mm) (p = 0.357). There was no significant differ-
ence in the yield for lesions greater than 20 mm diam-
eter as compared to lesions ≤ 20 mm in diameter (67.6 %
vs.70.8 %) (p = 0.840). Lobar location of the lesion also
did not affect diagnostic outcome (p = 0.590). Mean le-
sion distance from pleura was 16.8 ± 13.5 mm.
Overall complication rate was 6.4 % [Table 5]. Seven
patients (5.6 %) had bleeding that required cold saline or
topical adrenaline for haemostasis and 1 patient (0.8 %)
suffered a pneumothorax that was managed conservatively
without requiring chest drainage. All complications were
self-limited and no patient required escalation in the level
of care.
Discussion
Although previous studies that investigated PLLs using
bronchoscopy with radial EBUS guidance have demon-
strated a high sensitivity for the detection of malignant
lesions, it is worth noting that majority of the reports
came from populations with high incidence of malig-
nancy [17–20]. Lai et al. had a pulmonary TB incidence
of 23.5 %, and reported a sensitivity of 55 % for tubercu-
lous lesions diagnosed via conventional bronchoscopy
and fluoroscopy [15]. In comparison, the incidence of
pulmonary TB in our setting was 18.3 %. The addition
of radial EBUS with guide-sheath increased the diagnos-
tic sensitivity to 77.3 %, consistent with previous studies
that highlighted an increased yield could be obtained
when these 2 techniques are combined [5, 21, 22].
Another important finding from our study is that ra-
dial EBUS guided TBBs provided a more rapid diagnosis
via histology in nearly half of patients with pulmonary
TB, given their initial negative smear microscopy. Tuber-
culosis remains a global epidemic, and the ability to
diagnose pulmonary TB early is important from a clin-
ical and public health perspective. In 2011, there were
an estimated 8.7 million new cases of TB and 1.4 million
deaths from TB [23]. Around 3 million new cases of TB
cases are diagnosed in South-East Asia each year, and
this region accounts for 39 % of the global burden of TB
[23]. Singapore, with an incidence of pulmonary tubercu-
losis of 50 per 100,000, is situated in a tuberculosis en-
demic region and offers a setting to further understand
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Table 1 Demographics, clinical-radiological data and bronchoscopic results of malignant and benign peripheral lung lesions
Malignant Benign p-value
Demographics
Subjects (n) 76 44
Age 65.1 ± 10.3 58.2 ± 15.0 0.004
Male gender (%) 60.5 70.5 0.326
Smoking (%) 44.6 33.3 0.247
Diabetes mellitus (%) 21.6 14.3 0.461
Presenting symptoms (n)
Cough 27 14 0.841
Dyspnoea 14 1 0.037
Weight Loss 12 4 0.440
Hemoptysis 5 4 0.721
Fever 2 5 0.097
Asymptomatic 23 16 0.442
Size
Mean (mm) 26 ± 12 24 ± 13 0.357
≤20 mm 28 (36.0) 21 (47.7)
>20 mm 48 (64.0) 23 (52.3)
Common radiologic characteristics
Spiculation/Lobulation 44 (57.9) 10 (23.8) <0.001
Cavitation 4 (5.3) 13 (31.0) <0.001
Ground gass/Semisolid 4 (5.3) 3 (7.1) 0.698
Appearance
Tree-in-bud changes 1 (1.3) 6 (13.6) 0.009
Distance of lesion from pleura (mm) 17 ± 13 16 ± 14 0.606
Lobar Position (n) 0.582
Right upper lobe 20 12
Right middle lobe 6 5
Right lower lobe 20 8
Left upper lobe 28 14
Left lower lobe 2 5
Final diagnosis
Non-small cell lung cancer 63 (82.9) Pulmonary tuberculosis 22 (50.0)
Pneumonia 15 (34.1)
Small cell lung cancer 2 (2.6) Other diagnoses
Pulmonary metastases 10 (13.2) Organising pneumonia 5 (11.4)
Bronchial carcinoid 1 (1.3) Scarring 2 (4.6)
Cases diagnosed by radial EBUS Non-small cell lung cancer 45 (59.2) Pulmonary tuberculosis 17 (38.6)
Pneumonia 12 (27.3)
Small cell lung cancer 2 (2.6) Other diagnoses
Pulmonary metastases 2 (2.6) Organising pneumonia 2 (4.5)
Bronchial carcinoid 1 (1.3) Scarring 2 (4.5)
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EBUS diagnostic yields for both malignant and tubercu-
lous diseases [24]. Early diagnosis and appropriate treat-
ment of infectious patients with pulmonary TB are
important steps to reduce transmission of Mycobacterium
Tuberculosis and to achieve disease elimination [23]. Ra-
dial EBUS aided in obtaining histological diagnosis con-
sistent with pulmonary TB infection in 58.8 % of our
pulmonary TB patients thus enabling pulmonologists to
diagnose the disease and start anti-tuberculous treatment
earlier. However, histology does not replace mycobacterial
cultures, which is the “gold standard” in diagnosis of pul-
monary TB that gives additional important information on
sensitivity to anti-tuberculous medications. Indeed, this is
very important in the era of drug-resistant TB [23].
Our study demonstrated a low complication rate
(6.4 %) comparable to previously reported safety data of
radial EBUS (0–7.4 %) [9]. This is much lower compared
to the generally quoted complication rate from percu-
taneous lung biopsy (15–25 %) [25, 26] with similar yield
of 68.6 % for pulmonary TB [27]. The ability to diagnose
pulmonary TB earlier with histology and low complica-
tion rate highlights the potential of radial EBUS as the
preferred first step in an algorithm to evaluate PLLs when
the pre-test probability of tuberculosis and malignancy are
similarly high or for high risk patients who may not be
able to tolerate the complication of pneumothorax (for ex-
ample, patients with emphysema or chronic obstructive
pulmonary disease). It is also noted that adding guide
sheaths to the procedure does not worsen the safety pro-
file and its use should be considered for sampling [28].
We postulate that our higher yield for benign lesions
could be due to such lesions having surrounding inflam-
mation with ill-defined borders - or in the case of pul-
monary TB, associated consolidation, centrilobular
nodules or tree-in-bud changes. In our group of pul-
monary TB patients, the following associated radiologic
characteristics were observed in addition to the PLLs:
cavitation (9 lesions), scarring (3 lesions) and ground
glass opacities (2 lesions). Another possible reason could
be that benign lesions are less likely to cause airway dis-
tortion, in contrast to malignant lesions that have been
recognized to directly compress and narrow the bron-
chus or indirectly narrow the proximal bronchial tree
due to enlarged peribronchial or submucosal lymph
nodes [29].
We report a sensitivity of 65.8 % for all malignant le-
sions, which is similar to yields obtained from previous
Table 1 Demographics, clinical-radiological data and bronchoscopic results of malignant and benign peripheral lung lesions
(Continued)
Yield based on known location of probe
Within lesion 49 (71.6) 29 (78.9)
Adjacent to lesion 16 (23.9) 6 (15.8)
Outside lesion 3 (4.5) 2 (5.3)
Data presented as mean + SD and n (%), unless otherwise stated
Table 2 Histologic and/or microbiologic results obtained from
specimens derived from EBUS-guided sampling as compared to












Total 76 44 120
Table 3 Evaluation of patients who had non-diagnostic
radial-EBUS guided bronchoscopy
Malignant n = 26
Final method of diagnosis
Percutaneous lung biopsy 12
Surgical lung biopsy 9
Radiologic progression of pulmonary metastases 2
Transbronchial needle aspiration of associated lymph
node metastases
1
Repeat bronchoscopic biopsy with radial EBUS guidance 1
Response to chemotherapy 1
Benign n = 11
Tuberculosis
Final method of diagnosis
Responded to anti-tuberculous therapy 3
Percutaneous lung biopsy 1
Surgical lung biopsy 1
Infection
Final method of diagnosis
Responded to anti-microbial therapy 3
Organising pneumonia
Final method of diagnosis
Repeat bronchoscopic biopsy with radial EBUS 2
By different bronchoscopist
Scarring
Final method of diagnosis
Interval stability on repeat imaging (up to 1 year) 1
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radial EBUS studies [9]. However, our diagnostic yield
for pulmonary metastases was much lower (20 %). This
can be explained by spread of pulmonary metastases being
haematogenous and not bronchial; hence visualization and
diagnostic yield of such lesions by EBUS may be lower.
This is supported by our observation that we could place
our probe within the metastatic lesion in only 30 % of
cases. Percutaneous lung biopsy might be more appropri-
ate in such cases.
We identified several limitations in our study. Firstly,
during the time of study, the use of nucleic acid amplifi-
cation (NAA) tests as well as molecular tests to detect
TB and mutations conferring rifampicin resistance (eg
Xpert MTB/RIF) were not widely available for routine
clinical use in our institution. The advantage of NAA is its
ability to provide results within 24–48 h, compared to 3–5
days for histology and 2–6 weeks for TB cultures [30].
NAA testing has a high positive predictive value (>95 %)
in AFB smear-positive sputum specimens (especially rele-
vant in settings in which non-tuberculous mycobacteria
are common). It can confirm the presence of Mycobac-
teria tuberculosis in 62.2–79.3 % of AFB smear-negative,
culture-positive specimens [31, 32]. In our study
group, all our pulmonary TB patients were sputum
AFB smear negative. Given the low sensitivity of
NAA in such patients and the fact that histology is
necessary for the diagnosis of malignancy, these tests
were unlikely to have made a huge impact in our
clinical decision to perform bronchoscopy and radial
EBUS. Secondly, being a retrospective analysis, selection
bias could not be excluded. However, this was minimized
by including all consecutive patients who received radial
EBUS guidance in our institution. This meant that we
could not apply clinical-radiologic models in predicting
the probability of malignancy or infection prior to
histologic investigation, which may subsequently influence
the diagnostic yield of EBUS-TBB. We did not include a
control group of patients with PPLs who underwent bron-
choscopy with conventional fluoroscopic biopsy for com-
parison of diagnostic yields, as such patients should have
been considered for an alternative procedure given the
published data on low yields from conventional biopsies.
Unlike previous reports where EBUS bronchoscopies were
performed by selected few experts, radial EBUS bronchos-
copies were performed by all 8 pulmonologists in our in-
stitution, hence variability in endoscopic competency may
have affected the yield. Nevertheless, our hospital has a
high bronchoscopic load with >1000 bronchoscopies per-
formed every year and all pulmonologists were experi-
enced bronchoscopists trained in EBUS at the same time.
Therefore, endoscopic competency would not be a major
factor in influencing the yield. Furthermore, this provides
‘real-world’ experience rather than procedures performed
by selected specialized experts. It has been reported that
performing trans-bronchial needle aspiration with radial
EBUS guidance further improves the diagnostic yield [33].
This technique was not available to our center at the time
of the study and could be evaluated in future studies. It
was previously reported that EBUS-guided biopsies with-
out the use of fluoroscopy had limited benefit for diagnos-
ing smaller (≤20 mm) lesions [17]. For our study, we
elected to combine both EBUS and fluoroscopy for opti-
mal guidance of the forceps. Thus, the exact usefulness of
EBUS may have been overestimated in our study especially
for smaller lesions. This may also account for our similar
diagnostic yields for smaller and larger lesions. Ideally, the
gold standard for final diagnosis should be histologic or
microbial confirmation of all PPLs. However, the risk-
benefit ratio of multiple diagnostic procedures was consid-
ered and we included patients who we were confident of
the final diagnosis based on appropriate observation or
treatment.
Limitations notwithstanding, the findings from our
study have several clinical implications. Taking into ac-
count the high diagnostic accuracy for both malignant
and benign lesions as well as the excellent safety profile
of radial EBUS guided TBBs, we suggest using this as
the first modality to investigate PLLs in which clinical
characteristics and sputum studies remain inconclusive.
This may in turn reduce morbidity and healthcare costs
for patients who ultimately have benign lesions. Sec-
ondly, in cases where pre-test probability of pulmonary
TB is high, whilst it is sufficient to obtain an eventual
microbiologic diagnosis with BAL alone, the added
benefit of a more rapid histologic diagnosis with radial
EBUS guided TBB should be considered [34]. To valid-
ate these recommendations, prospective studies should
be conducted in populations with a similar prevalence of
pulmonary TB. This will allow for further analysis of the
Table 4 Histologic and/or microbiologic results obtained from
specimens derived from EBUS-guided sampling as compared to
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test performance of radial EBUS of pulmonary TB with
the aim of creating a clear management algorithm of
PLLs.
Conclusion
In our population with a high incidence of pulmonary
TB, it is important to review the clinical and radiologic
characteristics of PLLs before deciding on choice of in-
vestigation for histologic diagnosis. Where clinical suspi-
cion of malignancy is indeterminate or when pulmonary
tuberculosis is suspected following initial negative spu-
tum studies, radial EBUS is to be considered as a viable
first step in the evaluation of PLLs. The additional yield,
faster time to diagnosis and favourable safety profile of
radial EBUS are the positive factors contributing to our
recommendation.
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